Vertex Pharmaceuticals Just Hit an All-Time High. Here's Why the Biotech Stock Could Soar Even More
The drugmaker should significantly mitigate its most important risk as it develops new products.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.